The Effect of the Hypocholesterolemic Drug Clofibrate on Liver Mitochondrial Biogenesis
Open Access
- 1 October 1974
- journal article
- Published by Elsevier BV
- Vol. 249 (20), 6495-6504
- https://doi.org/10.1016/s0021-9258(19)42184-4
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Increase in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the ratBiochemical Journal, 1972
- Effects of ethylp‐chlorophenoxyisobutyrate on biliary secretion of bile acids, cholesterol and phosphatidyl cholineLipids, 1972
- Clofibrate, inhibitor of intestinal cholesterogenesisBiochemical Pharmacology, 1971
- Increase in hepatic mitochondria on administration of ethyl α-p-chlorophenoxyisobutyrate to the ratBiochemical Journal, 1970
- Steroid MetabolismPublished by Elsevier BV ,1970
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965
- Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liverJournal of Lipid Research, 1965
- Experimental studies of the toxicity of atromid with particular reference to fine structural changes in the livers of rodentsJournal of Atherosclerosis Research, 1963
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962
- Catabolism in Vitro of CholesterolPublished by Elsevier BV ,1961